Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

The stock traded ex-date for a stock split in a 1:2 ratio in November 2016 and in a 1:5 ratio in September 2021 ...

Biocon plans to list its biosimilars business by March 2026, targeting a double-digit market share in the U.S. with five new ...

Malpani Pipes IPO allotment is finalized today, with investors able to check their status on Bigshare Services Pvt Ltd. The ...

Meta Platforms (NASDAQ: META) stock has benefited from considerable growth since its IPO in 2012. The social media giant, ...

Unfortunately, for most investors, CoreWeave stock isn't viable for gaining AI exposure. Those who qualify as accredited ...

Dr Agarwal's Health Care IPO allotment status: The basis of allotment for Dr Agarwal's Health Care and Infra Solutions IPO ...

In case you haven't heard, there's a new president in town, and he's determined to shake up the Washington, D.C. establishment, cut red tape, and reduce spending. Investors in defense stocks seem a ...

With so much money already, and such a high market cap, you might think Anduril would be in no rush to IPO. However, earlier this month, Luckey told Bloomberg that Anduril is in fact "on a path to ...

The tally of publicly traded companies in the U.S. fell from about 8,800 in 1997 to just 3,952 by the end of 2024. The famed ...

And Anduril founder Palmer Luckey says this defense technology stock is "on a path to" IPO. Anduril could be the next Palantir -- in more ways than one. Attention, defense investors! In case you ...

The 23 stocks that debuted in India so far this year are up by an average of 15% from their offer prices, according to data ...